Secondary Metabolites from Food-Derived Yeasts Inhibit Virulence of <named-content content-type="genus-species">Candida albicans</named-content>

ABSTRACT A sparse number of available antifungal drugs, therapeutic side effects, and drug resistance are major challenges in current antifungal therapy to treat Candida albicans-associated infections. Here, we describe two food-derived yeasts, Saccharomyces cerevisiae and Issatchenkia occidentalis,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lohith Kunyeit, Nawneet K. Kurrey, K. A. Anu-Appaiah, Reeta P. Rao
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/c0108ff4dc6241c7a072179e6360ff8f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!